Anxiety and depression severity are related to right but not left onset Parkinson's disease duration

Journal of the Neurological Sciences

Volumn 305, Issue 1-2, 2011, Pages 131-135

  Foster, Paul S ^a,b   Drago, Valeria ^b,c,d   Crucian, Gregory P ^e,f   Sullivan, William K ^a   Rhodes, Robert D ^g   Shenal, Brian V ^c   Skoblar, Barry ^b   Skidmore, Frank M ^b,c   Heilman, Kenneth M ^b,c  

^a MIDDLE TENNESSEE STATE UNIVERSITY   (United States)

^b UNIVERSITY OF FLORIDA   (United States)

^c Malcom Randall VAMC   (United States)

^d IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^e UNIVERSITY OF CANTERBURY   (New Zealand)

^f BURWOOD HOSPITAL   (New Zealand)

^g Business Administration and Division of Business and Economics   (United States)

Author keywords

Anxiety; Depression; Duration; Lateral Onset; Parkinson's disease

Indexed keywords

AGED; ANXIETY; ARTICLE; BECK DEPRESSION INVENTORY; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; DISEASE SEVERITY; FEMALE; GERIATRIC DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARKINSON DISEASE; PRIORITY JOURNAL; SCORING SYSTEM; STATE TRAIT ANXIETY INVENTORY;

AGE OF ONSET; AGED; ANXIETY DISORDERS; DEPRESSIVE DISORDER; FEMALE; FUNCTIONAL LATERALITY; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; TIME FACTORS;

EID: 79955700249     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2011.02.023     Document Type: Article

References (65)

1. Gainotti G.Emotional behavior andhemispheric side of the lesion. Cortex 1972;8:41-55.
2. Hama S, Yamashita H, Shigenobu M, Watanabe A, Kurisu K, Yamawaki S, et al. Post-stroke affective or apathetic depression and lesion location: left frontal lobe and bilateral basal ganglia. Eur Arch Psychiatry Clin Neurosci 2007;257:149-52. (Pubitemid 46599128)
3. Morris PL, Robinson RG, Raphael B, Hopwood MJ. Lesion location and poststroke depression. J Neuropsychiatry Clin Neurosci 1996;8:399-403. (Pubitemid 26381961)
4. Shimoda K, Robinson RG. The relationship between poststroke depression and lesion location in long-term follow-up. Biol Psychiatry 1999;45:187-92. (Pubitemid 29079449)
5. Starkstein SE, Robinson RG, Honig MA, Parikh RM, Joselyn J, Price TR. Mood changes after right-hemisphere lesions. Br J Psychiatry 1989;155:79-85. (Pubitemid 19188752)
6. Kumar A, Bilker W, Lavretsky H, Gottlieb G. Volumetric asymmetries in late-onset mood disorders: an attenuation of frontal asymmetry with depression severity. Psychiatry Res 1984;100:41-7.
7. Debener S, Beauducel A, Nessler D, Brocke B, Heilemann H, Kayser J. Is resting anterior EEG alpha asymmetry a trait marker for depression? Neuropsychobiology 2000;41:31-7.
8. Henriques JB, Davidson RJ. Left frontal hypoactivation in depression. J Abnorm Psychol 1991;100:535-45.
9. Schaffer CE, Davidson RJ, Saron C. Frontal andparietal electroence phalograma symmetry in depressed and nondepressed subjects. Biol Psychiatry 1983;18:753-62. (Pubitemid 13073958)
10. Henriques JB, Davidson RJ. Regional brain electrical asymmetries discriminate between previously depressed and healthy control subjects. J Abnorm Psychol 1990;99:22-31. (Pubitemid 20117083)
11. Vuga M, Fox NA, Cohn JF, George CJ, Levenstein RM, Kovacs M. Long-term stability of frontal electroencephalographic asymmetry in adults with a history of depression and controls. Int J Psychophysiol 2006;59:107-15. (Pubitemid 43138729)
12. Thibodeau R, Jorgensen RS, Kim S. Depression, anxiety, and resting frontal EEG asymmetry: a meta-analytic review. J Abnorm Psychol 2006;115:715-29. (Pubitemid 44747800)
13. Baving L, Laucht M, Schmidt MH. Frontal brain activation in anxious school children. J Child Psychol Psychiatry 2002;43:265-74. (Pubitemid 36939216)
14. Blackhart GC, Minnix JA, Kline JP. Can EEG asymmetry patterns predict future development of anxiety and depression? A preliminary study. Biol Psychol 2006;72:46-50. (Pubitemid 43331015)
15. Foster PS, Harrison DW. Quantitative electroencephalographic assessment of an individual with comorbid depression and panic attacks. Arch Clin Neuropsychol 2002;17:808-9.
16. Nitschke JB, Heller W, Palmieri PA, Miller GA. Contrasting patterns of brain activity in anxious apprehension and anxious arousal. Psychophysiology 1999;36:628-37. (Pubitemid 29357558)
17. Wiedemann G, Pauli P, Dengler W, Lutzenberger W, Birbaumer N, Buchkremer G. Frontal brain asymmetry as a biological substrate of emotions in patients with panic disorders. Arch Gen Psychiatry 1999;56:78-84. (Pubitemid 29055053)
18. Hoehn MM, Yahr MD. Parkinsonism: onset, progression, and mortality. Neurology 1967;17:427-42.
19. Hughes AJ, Ben-Shlomo Y, Daniel SE, Lees AJ. What features improve the accuracy of clinical diagnosis in Parkinson's disease: a clinicopathological study. Neurology 1992;42:1142-6.
20. Leentjens AFG, Lousberg R, Verhey FRJ. Markers for depression in Parkinson's disease. Acta Psychiatr Scand 2002;106:196-201.
21. Rajput AH, Pahwa R, Pahwa P, Rajput A. Prognostic significance of the onset mode in parkinsonism. Neurology 1993;43:829-30. (Pubitemid 23121983)
22. Shulman LM, Taback RL, Rabinstein AA, Weiner WJ. Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism Relat Disord 2002;8:193-7. (Pubitemid 33091403)
23. Huang WS, Lin SZ, Lin JC, Wey SP, Ting G, Liu RS. Evaluation of early-stage Parkinson's disease with 99mTc-TRODAT-1 imaging. J Nucl Med 2001;42:1303-8. (Pubitemid 32852603)
24. Kempster PA, Gibb WRG, Stern GM, Lees AJ. Asymmetry of substantia nigraneuronal loss in Parkinson's disease and its relevance to the mechanism of levodopa related motor fluctuations. J Neurol Neurosurg Psychiatry 1989;52:72-6. (Pubitemid 19043874)
25. 11C]DTBZ-PET correlates of levodopa responses in asymmetric Parkinson's disease. Brain 2003;126:2648-55.
26. Leenders KL, Salmon EP, Tyrrell P, Perani D, Brooks DJ, Sager H, et al. The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson's disease. Arch Neurol 1990;47:1290-8.
27. Tatsch K, Schwarz J, Mozley PD, Linke R, Pogarell O, Oertel WH, et al. Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [123I]IPT and single-photon emission tomography. Eur J Nucl Med 1997;24:415-21. (Pubitemid 27183046)
28. Cole SA, Woodard JL, Juncos JL, Kogos JL, Youngstrom EA, Watts RL. Depression and disability in Parkinson's disease. J Neuropsychiatry Clin Neurosci 1996;8:20-5. (Pubitemid 26044696)
29. Fleminger S. Left-sided Parkinson's disease is associated with greater anxiety and depression. Psychol Med 1991;21:629-38.
30. Weintraub D, Newberg AB, Cary MS, Siderowf AD, Moberg PJ, Kleiner-Fisman G, et al. Striatal dopamine transporter imaging correlates with anxiety and depression symptoms in Parkinson's disease. J Nucl Med 2005;46:227-32. (Pubitemid 43073428)
31. Aarslad D, Larsen JP, Lim NG, Janvin C, Karlsen K, Tandberg E, et al. Range of neuropsychiatric disturbances in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry 1999;67:492-6. (Pubitemid 29438205)
32. Huber SJ, Freidenberg DL, Shuttleworth EC, Paulson GW, Clapp LE. Neuropsychological similarities in lateralized Parkinsonism. Cortex 1989;25:461-70. (Pubitemid 19244895)
33. Katzen HL, Levin BE, Weiner W. Side and type of motor symptom influence cognition in Parkinson's disease. Mov Disord 2006;21:1947-53. (Pubitemid 44848943)
34. Spicer KB, Roberts RJ, LeWitt PA. Neuropsychological performance in lateralized Parkinsonism. Arch Neurol 1988;45:429-32. (Pubitemid 18098284)
35. St. Clair J, Borod JC, Sliwinski M, Cote LJ, Stern Y. Cognitive and affective functioning in Parkinson's disease patients with lateralized motor signs. J Clin Exp Neuropsychol 1998;20:320-7. (Pubitemid 28539552)
36. Tomer R, Levin BE, Weiner WJ. Side of onset of motor symptoms influences cognition in Parkinson's disease. Ann Neurol 1993;34:579-84. (Pubitemid 23289410)
37. Lee CS, Schulzer M, Mak E, Hammerstad JP, Calne S, Calne DB. Patterns of asymmetry do not change over the course of idiopathic parkinsonism: implications for pathogenesis. Neurology 1995;45:435-9.
38. Martin WRW, Calne DB. Imaging techniques and movement disorders. In: Marsden CD, Fahn S, editors. Movement Disorders 2. London: Butterworths; 1987. p. 4-16.
39. Fross RD, Tsin JKC, McLennan DJ, Schultzer M, Calne DB. Asymmetry in Parkinson's disease. Neurology 1987;37(Suppl):320.
40. Rojo A, Aguilar M, Garolera MT, Cubo E, Navas I, Quintana NS. Depression in Parkinson's disease: clinical correlates and outcome. Parkinsonism Relat Disord 2003;10:23-8. (Pubitemid 37117388)
41. Schrag A, Jahanshahi M, Quinn NP. What contributes to depression in Parkinson's disease? Psychol Med 2001;31:65-73.
42. Huber SJ, Freidenberg DL, Paulson GW, Shuttleworth EC, Christy JA. The pattern of depressive symptoms varies with progression of Parkinson's disease. J Neurol Neurosurg Psychiatry 1990;53:275-8. (Pubitemid 20152004)
43. Siemers ER, Shekhar A, Quaid K, Dickson H. Anxiety and motor performance in Parkinson's disease. Mov Disord 1993;8:501-6. (Pubitemid 23291206)
44. Cubo E, Martin PM, Martin-Gonzalez JA, Rodriguez-Blazquez C, Kulisevsky J, ELEP Group Members. Motor laterality asymmetry and nonmotor symptoms in Parkinson's disease. Mov Disord 2010;25:70-5.
45. Beck AT, Steer RA, Brown GK. Beck Depression Inventory-II. San Antonio, TX: Harcourt Assessment, Inc.; 1996.
46. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1983;17:37-49. (Pubitemid 13123113)
47. Spielberger CD. State-Trait Anxiety Inventory (Form Y). Redwood City, CA: Mind Garden; 1983.
48. Macht M, Schwarz R, Ellgring H. Patterns of psychological problems in Parkinson's disease. Acta Neurol Scand 2005;111:95-101. (Pubitemid 40175331)
49. Nuti A, Ceravolo R, Piccinni A, Dell'Agnello G, Bellini G, Gambaccini G, et al. Psychiatric comorbidity in a population of Parkinson's disease patients. Eur J Neurol 2004;11:315-20. (Pubitemid 38903564)
50. Shulman LM, Taback RLT, Bean J, Weiner WJ. Comorbidity of the nonmotor symptoms of Parkinson's disease. Mov Disord 2001;16:507-10. (Pubitemid 36041156)
51. Wichowicz HM, Slawek J, Derejko M, Cubala WJ. Factors associated with depression in Parkinson's disease: a cross-sectional study in a Polish population. Eur Psychiatry 2006;21:516-20. (Pubitemid 44856773)
52. Steinbusch HWM. Distribution of serotonin-immunoreactivity in the central nervous system of the rat - cell bodies and terminals. Neuroscience 1981;6:557-618. (Pubitemid 11102583)
53. Lee HS, Kim MA, Valentino RJ, Waterhouse BD. Glutamatergic afferent projections to the dorsal raphe nucleus of the rat. Brain Res 2003;963:57-71. (Pubitemid 36126286)
54. Del Tredici K, Rub U, De Vos RA, Bohl JR, Braak H. Where does parkinson disease pathology begin in the brain? J Neuropathol Exp Neurol 2002;61:413-26.
55. Halliday GM, Blumbergs PC, Cotton RG, Blessing WW, Geffen LB. Loss of brainstem serotonin- and substance P-containing neurons in Parkinson's. Brain Res 1990;510:104-7. (Pubitemid 20060808)
56. Messer T, Schmauss M, Lambert-Baumann J. Efficacy and tolerability of reboxetine in depressive patients treated in routine clinical practice. CNS Drugs 2005;19:43-54. (Pubitemid 40165156)
57. Montgomery S, Ferguson JM, Schwartz GE. The antidepressant efficacy of reboxetine in patients with severe depression. J Clin Psychopharmacol 2003;23:45-50. (Pubitemid 36164425)
58. Nelson JC, Portera L, Leon AC. Are there differences in the symptoms that respond to a selective serotonin or norepinephrine reuptake inhibitor? Biol Psychiatry 2005;57:1535-42.
59. Berrios GE, Campbell C, Politynska BE. Autonomic failure, depression and anxiety in Parkinson's disease. Br J Psychiatry 1995;166:789-92.
60. Korchounov A, Kessler KR, Yakhno NN, Damulin IV, Schipper HI. Determinants of autonomic dysfunction in idiopathic Parkinson's disease. J Neurol 2005;252:1530-6. (Pubitemid 41803845)
61. Goldstein DS. Orthostatic hypotension as an early finding in Parkinson's disease. Clin Auton Res 2006;16:46-54. (Pubitemid 43237902)
62. Bowers D, Miller K, Mikos A, Kirsch-Darrow L, Springer U, Fernandez H, et al. Startling facts about emotion in Parkinson's disease: blunted reactivity to aversive stimuli. Brain 2006;129:3356-65. (Pubitemid 44871448)
63. Ferreira JJ, Desboeuf K, Galitzky M, Thalamas C, Brefel-Courbon C, Fabre N, et al. Sleep disruption, daytime somnolence and 'sleep attacks' in Parkinson's disease: a clinical survey in PD patients and age-matched healthy volunteers. Eur J Neurol 2006;13:209-14.
64. Gjerstad MD, Alves G, Wentzel-Larsen T, Aarsland D, Larsen JP. Excessive daytime sleepiness in Parkinson disease: is it the drugs or the disease? Neurology 2006;67:853-8.
65. Heilman KM, Schwartz HD, Watson RT. Hypoarousal in patients with the neglect syndrome and emotional indifference. Neurology 1978;28:229-32. (Pubitemid 8312868)